Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 49 | ECE2017 | Next issue

19th European Congress of Endocrinology

Lisbon, Portugal
20 May 2017 - 23 May 2017

Card image cap
20-23 May 2017, Lisbon, Portugal Further information

Symposia

Evolving diagnostics in adrenal and neuroendocrine tumours

ea0049s2.1 | Evolving diagnostics in adrenal and neuroendocrine tumours | ECE2017

Role of genetic and biomarker tests for diagnosis of neuroendocrine tumours (NETs)

Thakker Raj

Neuroendocrine tumours (NETs) are a heterogeneous group of neoplasms that occur in different organs and give rise to tumours including carcinoids, pancreatic tumours (PNETs), pituitary adenomas, medullary thyroid carcinoma, and phaeochromocytomas. NETs usually occur as isolated non-familial tumours, but can also occur as hereditary and syndromic disorders, such as multiple endocrine neoplasia (MEN types 1–4), Von Hippel Lindau (VHL) and phaeochromocytoma/paraganglioma. Pa...

ea0049s2.2 | Evolving diagnostics in adrenal and neuroendocrine tumours | ECE2017

Current status in morphological imaging in adrenal and gastrointestinal neuroendocrine tumours

Anders Sundin

Computed Tomography (CT) constitutes the basic technique for imaging of adrenal tumours and neuroendocrine tumours (NETs). The major work-load in adrenal imaging is characterisation of adrenal incidentalomas, i.e. adrenal tumours diagnosed on imaging performed for other reasons than adrenal disease. Myelolipomas, which have a typical appearance with areas of macroscopic fat, and simple cysts are easy to characterize and require no follow-up. Morphologically benign adrenal tumo...